Who invested in Qool Therapeutics?
Qool Therapeutics's investors include MBX Capital, BioPacific, BrilliMedical, Join and TAMCAP, and 2 more on record.
United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$8.3Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
No investor was named in the report.
From a historical funding recordSEC filing: $250K sold, first sale Oct 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Qool Therapeutics's investors include MBX Capital, BioPacific, BrilliMedical, Join and TAMCAP, and 2 more on record.
Qool Therapeutics has raised $8.3M across 2 rounds since 2015.
Qool Therapeutics's most recent round was a Series A of $8.0M in Nov 2017.
Its most recent round, $8.0M in Nov 2017, is also its largest on record.
Qool Therapeutics's first round on record, in Nov 2017, was backed by MBX Capital, BioPacific and BrilliMedical and 4 others.
Qool Therapeutics's latest named round is a Series A, in Nov 2017.
Qool Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.